{"entity":{"type":"insider","cik":"0001748808","url":"/insider/0001748808","json_url":"/insider/0001748808.json","name":"Otto Dawn Parsell","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":45,"n_filings":16,"first":"2019-01-08","last":"2020-05-12","span_basis":"filed_date"},"name_variants":[{"name":"Otto Dawn Parsell","source":"filing","n_filings":16,"first_seen":"2019-01-08","last_seen":"2020-05-12"}],"transactions":[{"id":2272781,"accession":"0001595585-20-000068","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001595585-20-000068","line_url":"/filing/0001595585-20-000068","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (EVP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (EVP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":31.98,"price_display":"31.98","price_state":"stated","total_value":95940.0,"total_display":"95,940.00","total_whole":"95,940","shares_owned_after":255.0,"shares_owned_after_display":"255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-08","filed_date":"2020-05-12","scope":"insider","n_lines":4},{"id":2042657,"accession":"0001595585-20-000064","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001595585-20-000064","line_url":"/filing/0001595585-20-000064","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (EVP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (EVP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":30.144016,"price_display":"30.14","price_state":"stated","total_value":37680.02,"total_display":"37,680.02","total_whole":"37,680","shares_owned_after":255.0,"shares_owned_after_display":"255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-07","scope":"insider","n_lines":2},{"id":2319588,"accession":"0001595585-20-000055","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001595585-20-000055","line_url":"/filing/0001595585-20-000055","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (EVP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (EVP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":31.98,"price_display":"31.98","price_state":"stated","total_value":95940.0,"total_display":"95,940.00","total_whole":"95,940","shares_owned_after":255.0,"shares_owned_after_display":"255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-29","filed_date":"2020-04-30","scope":"insider","n_lines":4},{"id":2319559,"accession":"0001595585-20-000055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001595585-20-000055","line_url":"/filing/0001595585-20-000055#line-2","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (EVP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (EVP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":29.98,"price_display":"29.98","price_state":"stated","total_value":37475.0,"total_display":"37,475.00","total_whole":"37,475","shares_owned_after":255.0,"shares_owned_after_display":"255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-28","filed_date":"2020-04-30","scope":"insider"},{"id":2620383,"accession":"0001595585-20-000037","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001595585-20-000037","line_url":"/filing/0001595585-20-000037","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (EVP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (EVP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4250.0,"shares_display":"4,250","price_per_share":31.839105882352943,"price_display":"31.84","price_state":"stated","total_value":135316.2,"total_display":"135,316.20","total_whole":"135,316","shares_owned_after":255.0,"shares_owned_after_display":"255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider","n_lines":4},{"id":2716372,"accession":"0001595585-20-000011","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001595585-20-000011","line_url":"/filing/0001595585-20-000011","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (Sr VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4250.0,"shares_display":"4,250","price_per_share":36.86316941176471,"price_display":"36.86","price_state":"stated","total_value":156668.47,"total_display":"156,668.47","total_whole":"156,668","shares_owned_after":655.0,"shares_owned_after_display":"655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-03","filed_date":"2020-02-05","scope":"insider","n_lines":6},{"id":3062112,"accession":"0001595585-20-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001595585-20-000003","line_url":"/filing/0001595585-20-000003","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (Sr VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4250.0,"shares_display":"4,250","price_per_share":37.04032941176471,"price_display":"37.04","price_state":"stated","total_value":157421.4,"total_display":"157,421.40","total_whole":"157,421","shares_owned_after":255.0,"shares_owned_after_display":"255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-06","scope":"insider","n_lines":2},{"id":7791871,"accession":"0001595585-19-000268","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001595585-19-000268","line_url":"/filing/0001595585-19-000268","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (Sr VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5746.0,"shares_display":"5,746","price_per_share":39.60133658197007,"price_display":"39.60","price_state":"stated","total_value":227549.28,"total_display":"227,549.28","total_whole":"227,549","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-26","filed_date":"2019-11-27","scope":"insider","n_lines":4},{"id":8715740,"accession":"0001595585-19-000242","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001595585-19-000242","line_url":"/filing/0001595585-19-000242","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (Sr VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":37.2525320754717,"price_display":"37.25","price_state":"stated","total_value":197438.42,"total_display":"197,438.42","total_whole":"197,438","shares_owned_after":1531.0,"shares_owned_after_display":"1,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-28","filed_date":"2019-10-30","scope":"insider","n_lines":6},{"id":8656535,"accession":"0001595585-19-000213","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001595585-19-000213","line_url":"/filing/0001595585-19-000213","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (Sr VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":32.50130566037736,"price_display":"32.50","price_state":"stated","total_value":172256.92,"total_display":"172,256.92","total_whole":"172,257","shares_owned_after":271.0,"shares_owned_after_display":"271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-25","filed_date":"2019-09-27","scope":"insider","n_lines":3},{"id":8172170,"accession":"0001595585-19-000192","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001595585-19-000192","line_url":"/filing/0001595585-19-000192","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (Sr VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":33.691,"price_display":"33.69","price_state":"stated","total_value":168455.0,"total_display":"168,455.00","total_whole":"168,455","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-28","filed_date":"2019-08-30","scope":"insider","n_lines":2},{"id":7958819,"accession":"0001595585-19-000147","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001595585-19-000147","line_url":"/filing/0001595585-19-000147#line-2","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (Sr VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":31.19,"price_display":"31.19","price_state":"stated","total_value":155950.0,"total_display":"155,950.00","total_whole":"155,950","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-29","filed_date":"2019-07-30","scope":"insider"},{"id":7791857,"accession":"0001595585-19-000125","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001595585-19-000125","line_url":"/filing/0001595585-19-000125#line-4","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (Sr VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15407.0,"shares_display":"15,407","price_per_share":37.04,"price_display":"37.04","price_state":"stated","total_value":570675.28,"total_display":"570,675.28","total_whole":"570,675","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-03","filed_date":"2019-07-05","scope":"insider"},{"id":8019058,"accession":"0001595585-19-000070","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001595585-19-000070","line_url":"/filing/0001595585-19-000070#line-3","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (Sr VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15500.0,"shares_display":"15,500","price_per_share":30.74,"price_display":"30.74","price_state":"stated","total_value":476470.0,"total_display":"476,470.00","total_whole":"476,470","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-28","filed_date":"2019-03-29","scope":"insider"},{"id":7826482,"accession":"0001595585-19-000050","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001595585-19-000050","line_url":"/filing/0001595585-19-000050#line-4","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (Sr VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1729.0,"shares_display":"1,729","price_per_share":25.02,"price_display":"25.02","price_state":"stated","total_value":43259.58,"total_display":"43,259.58","total_whole":"43,260","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-18","filed_date":"2019-03-19","scope":"insider"},{"id":7826476,"accession":"0001595585-19-000050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001595585-19-000050","line_url":"/filing/0001595585-19-000050#line-2","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (Sr VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":771.0,"shares_display":"771","price_per_share":25.02,"price_display":"25.02","price_state":"stated","total_value":19290.42,"total_display":"19,290.42","total_whole":"19,290","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-15","filed_date":"2019-03-19","scope":"insider"},{"id":8354246,"accession":"0001595585-19-000046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001595585-19-000046","line_url":"/filing/0001595585-19-000046#line-2","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (Sr VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-13","filed_date":"2019-03-15","scope":"insider"},{"id":8749391,"accession":"0001595585-19-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001595585-19-000009","line_url":"/filing/0001595585-19-000009#line-1","is_derivative":false,"issuer_cik":"0001595585","issuer_name":"Tricida, Inc.","issuer_ticker":"TCDA","issuer_name_source":null,"issuer_url":"/issuer/0001595585","owner_cik":"0001748808","owner_name":"Otto Dawn Parsell","owner_display_name":"Otto Dawn Parsell","owner_url":"/insider/0001748808","role":"Officer (Sr VP, Clinical Development)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":665.0,"shares_display":"665","price_per_share":23.27,"price_display":"23.27","price_state":"stated","total_value":15474.55,"total_display":"15,474.55","total_whole":"15,475","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-07","filed_date":"2019-01-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":45,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":45,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":45},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001595585","name":"Tricida, Inc.","url":"/issuer/0001595585","role":"Officer (EVP, Clinical Development)","n_filings":16,"first_seen":"2019-01-08","last_seen":"2020-05-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001748808","retrieved_at":"2026-08-24T23:15:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}